Abstract
Abstract
Background
We present a case of alpha-fucosidosis, a lysosomal storage disorder, from Egypt. The report also includes a brief review of the COVID-19 and lysosomal storage diseases relationship.
Case presentation
A female patient aged 18 years, diagnosed with type II fucosidosis, based on the cutaneous signs, characteristic facies, and systemic symptoms, and diagnosis was confirmed using genetic analysis. The patient died from COVID-19 pneumonia during the COVID-19 pandemic after getting the infection from her father and being hospitalized.
Conclusions
Patients with lysosomal storage diseases with local or systemic immune suppression may be predisposed to respiratory complications of COVID-19. Intense care with protective guidelines should be applied to those patients.
Publisher
Springer Science and Business Media LLC
Reference18 articles.
1. Willems PJ, Gatti R, Darby JK, Romeo G, Durand P, Dumon JE et al (1991) Fucosidosis revisited: a review of 77 patients. Am J Med Genet 38(1):111–131
2. Malatt C, Koning JL, Naheedy J (2015) Skeletal and brain abnormalities in fucosidosis, a rare lysosomal storage disorder. J Radiol Case Rep 9(5):30
3. Kanitakis J, Allombert C, Doebelin B, Deroo-Berger MC, Grande S, Blanc S et al (2005) Fucosidosis with angiokeratoma. Immunohistochem Electronmicroscopic study of a new case and literature review. J Cutaneous Pathol 32(7):506–511
4. Elsayed S (2018) Are we missing fucosidosis? Egypt J Med Hum Genet 19(2):151–152
5. Fleming C, Rennie A, Fallowfield M, McHenry P (1997) Cutaneous manifestations of fucosidosis. Br J Dermatol 136(4):594–597
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antibacterials/tocilizumab;Reactions Weekly;2022-10-15